The current leadership team at Optibrium has a wealth of experience in the field of ADMET and drug development. The team includes individuals who have previously worked as a Senior Director at BioFocus DPI, Head of Admensa Business Unit at Inpharmatica Ltd, and Associate Director at ArQule. Additionally, the team has members with education from some of the top universities in the UK, including the University of Cambridge and the University of Oxford. This combination of experience and education gives Optibrium the ability to develop innovative solutions for their clients.
View all